News
The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV ...
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...
Hosted on MSN22h
CVS Health Reportedly Keeps Gilead’s New HIV Preventative Shot Off Its Plans, Faces $290M Medicare Fraud Ruling
UnitedHealth Group’s OptumRx said it will assess Yeztugo in the coming weeks. CVS Caremark, OptumRx, and Express Scripts together control about 70% of specialty drug prescriptions in the United States ...
A federal judge has ordered CVS Health's PBM Caremark to pay nearly $290 million after a whistleblower accused the business of overcharging Medicare on prescription drugs more than a decade ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback